Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Rituximab for the Treatment of Primary Membranous Nephropathy: CADTH Health Technology Review [Internet].
Authors; Islam S, Janoudi G, Bryan M, Perras C, Jabr M, Haines A, Assasi N, Boucher J, Hafizi D, Lafleur P, Black C, Cornelissen, T, Ford C. Authors, et al. Among authors: perras c. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Apr. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Apr. PMID: 38232188 Free Books & Documents. Review. No abstract available.
Inclisiran: A Small Interfering RNA Molecule for Treating Hypercholesterolemia.
Klinovski M, Boucher M, Perras C, Grobelna A. Klinovski M, et al. Among authors: perras c. 2019 Dec 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 180. 2019 Dec 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 180. PMID: 32239882 Free Books & Documents. Review.
Esketamine for Treatment-Resistant Depression.
Tibensky BN, de Léséleuc L, Perras C, Picheca L. Tibensky BN, et al. Among authors: perras c. 2019 Apr 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 176. 2019 Apr 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 176. PMID: 31211546 Free Books & Documents. Review.
Monoclonal Antibodies to Prevent Migraine Headaches.
Ibekwe A, Perras C, Mierzwinski-Urban M. Ibekwe A, et al. Among authors: perras c. 2018 Feb 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 167. 2018 Feb 1. In: CADTH Issues in Emerging Health Technologies. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016–2021. 167. PMID: 30855775 Free Books & Documents. Review.
29 results